FindTrial
Sign In

COMPARISON OF EPIDURAL(OUTSIDE SPINAL CORD)DEXAMETHASONE (STEROID)AND EPIDURAL MORPHINE(OPIOID)FOR POST OPERATIVE PAIN RELIEF IN TOTAL ABDOMINAL HYSTERECTOMY(REMOVAL OF UTERUS)

COMPARISON OF EPIDURAL DEXAMETHASONE AND EPIDURAL MORPHINE FOR POST OPERATIVE ANALGESIA IN TOTAL ABDOMINAL HYSTERECTOMY

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/11/038020
Enrollment
60
Registered
2021-11-12
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: EPIDURAL DEXAMETHASONE: 8MG DEXAMETHASONE (2 ML) AS AN ADDITIVE TO 8ML 0.5% BUPIVACAINE EPIDURALLY IN ONE GROUP (ONE YEAR STUDY) Control Intervention1: EPIDURAL MORPHINE: 4MG MORPHINE I

Sponsors

VINAYAKA MISSIONS KIRUPANANDA VARIYAR MEDICAL COLLEGE AND HOSPITALS
Lead Sponsor
VIGNESHWARAN
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: ASA 1 AND 2 PATIENTS UNDERGOING TOTAL ABDOMINAL HYSTERECTOMY UNDER EPIDURAL ANESTHESIA

Exclusion criteria

Exclusion criteria: PATIENTS WHO ARE NOT WILLING FOR TRIAL, ALLERGIC TO DRUGS USED IN THE TRIAL, ASA GRADE 3 & 4, PATIENTS WHO ARE CONTRAINDICATED FOR EPIDURAL ANESTHESIA, PATIENTS REQUIRING GENERAL ANESTHESIA

Design outcomes

Primary

MeasureTime frame
TO DETERMINE THE POSTOPERATIVE ANALGESIC EFFICACY OF EPIDURAL DEXAMETHASONE AND EPIDURAL MORHINE AS ADDITIVES TO BUPIVACAINE USING VISUAL ANALOG SCALETimepoint: POST OPERATIVE ANALGESIA WILL BE ASSESSED UPTO 24 HOURS—

Secondary

MeasureTime frame
TO ASSESS THE ADVERSE EFFECTS OF EPIDURAL DEXAMETHASONE AND MORPHINETimepoint: ADVERSE EFFECTS WILL BE MONITORED FOR 24 HOURS—

Countries

India

Contacts

Public ContactPRIYANKA CHANDRAN

VINAYAKA MISSIONS KIRUPANANDA VARIYAR MEDICAL COLLEGE AND HOSPITALS

DRVIGNESHWARANS@GMAIL.COM9789092597

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026